Zynex Inc
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more
Zynex Inc (ZYXI) - Net Assets
Latest net assets as of September 2025: $-41.37 Million USD
Based on the latest financial reports, Zynex Inc (ZYXI) has net assets worth $-41.37 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($45.32 Million) and total liabilities ($86.69 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-41.37 Million |
| % of Total Assets | -91.28% |
| Annual Growth Rate | 60.92% |
| 5-Year Change | -37.19% |
| 10-Year Change | N/A |
| Growth Volatility | 55885.72 |
Zynex Inc - Net Assets Trend (1999–2024)
This chart illustrates how Zynex Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Zynex Inc (1999–2024)
The table below shows the annual net assets of Zynex Inc from 1999 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $35.71 Million | -22.59% |
| 2023-12-31 | $46.13 Million | -30.48% |
| 2022-12-31 | $66.36 Million | -10.24% |
| 2021-12-31 | $73.92 Million | +30.02% |
| 2020-12-31 | $56.85 Million | +189.29% |
| 2019-12-31 | $19.65 Million | +111.37% |
| 2018-12-31 | $9.30 Million | +89.68% |
| 2017-12-31 | $4.90 Million | +228.93% |
| 2016-12-31 | $-3.80 Million | +6.61% |
| 2015-12-31 | $-4.07 Million | -221.31% |
| 2014-12-31 | $-1.27 Million | -126.13% |
| 2013-12-31 | $4.85 Million | -59.78% |
| 2012-12-31 | $12.05 Million | +18.89% |
| 2011-12-31 | $10.14 Million | +23.93% |
| 2010-12-31 | $8.18 Million | +9.29% |
| 2009-12-31 | $7.49 Million | +56.81% |
| 2008-12-31 | $4.77 Million | +31.97% |
| 2007-12-31 | $3.62 Million | +180.98% |
| 2006-12-31 | $1.29 Million | +192.09% |
| 2005-12-31 | $440.77K | +117.24% |
| 2004-12-31 | $202.89K | +144.00% |
| 2003-12-31 | $-461.11K | +22.50% |
| 2000-12-31 | $-594.94K | -243929.51% |
| 1999-12-31 | $244.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Zynex Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3161213200.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $29.77 Million | 83.38% |
| Common Stock | $32.00K | 0.09% |
| Other Components | $5.90 Million | 16.53% |
| Total Equity | $35.71 Million | 100.00% |
Zynex Inc Competitors by Market Cap
The table below lists competitors of Zynex Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Haffner Energy SA
PA:ALHAF
|
$1.36 Million |
|
GOLDREA RES CORP.
F:GOJ1
|
$1.36 Million |
|
Slam Exploration Ltd
PINK:SLMXF
|
$1.36 Million |
|
Master Drilling Group Ltd
JSE:MDI
|
$1.36 Million |
|
TE CONNECTIV N (9TC.SG)
STU:9TC
|
$1.36 Million |
|
Route 109 Resources Inc.
V:RTE
|
$1.36 Million |
|
The Grob Tea Company Limited
NSE:GROBTEA
|
$1.36 Million |
|
Martela Oyj A
HE:MARAS
|
$1.36 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zynex Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 46,129,000 to 35,708,000, a change of -10,421,000 (-22.6%).
- Net income of 2,994,000 contributed positively to equity growth.
- Dividend payments of 9,000 reduced retained earnings.
- Share repurchases of 15,625,000 reduced equity.
- Other factors increased equity by 2,219,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.99 Million | +8.38% |
| Dividends Paid | $9.00K | -0.03% |
| Share Repurchases | $15.62 Million | -43.76% |
| Other Changes | $2.22 Million | +6.21% |
| Total Change | $- | -22.59% |
Book Value vs Market Value Analysis
This analysis compares Zynex Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.08x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 5.65x to 0.08x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $0.02 | $0.09 | x |
| 1999-12-31 | $0.09 | $0.09 | x |
| 2000-12-31 | $-249.35 | $0.09 | x |
| 2001-12-31 | $-603.78 | $0.09 | x |
| 2002-12-31 | $-6.47 | $0.09 | x |
| 2003-12-31 | $-0.04 | $0.09 | x |
| 2004-12-31 | $0.01 | $0.09 | x |
| 2005-12-31 | $0.02 | $0.09 | x |
| 2006-12-31 | $0.05 | $0.09 | x |
| 2007-12-31 | $0.12 | $0.09 | x |
| 2008-12-31 | $0.14 | $0.09 | x |
| 2009-12-31 | $0.22 | $0.09 | x |
| 2010-12-31 | $0.24 | $0.09 | x |
| 2011-12-31 | $0.30 | $0.09 | x |
| 2012-12-31 | $0.35 | $0.09 | x |
| 2013-12-31 | $0.14 | $0.09 | x |
| 2014-12-31 | $-0.03 | $0.09 | x |
| 2015-12-31 | $-0.12 | $0.09 | x |
| 2016-12-31 | $-0.11 | $0.09 | x |
| 2017-12-31 | $0.14 | $0.09 | x |
| 2018-12-31 | $0.25 | $0.09 | x |
| 2019-12-31 | $0.53 | $0.09 | x |
| 2020-12-31 | $1.48 | $0.09 | x |
| 2021-12-31 | $1.71 | $0.09 | x |
| 2022-12-31 | $1.70 | $0.09 | x |
| 2023-12-31 | $1.28 | $0.09 | x |
| 2024-12-31 | $1.11 | $0.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zynex Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.38%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.56%
- • Asset Turnover: 1.58x
- • Equity Multiplier: 3.42x
- Recent ROE (8.38%) is above the historical average (-1286.60%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | -13803.28% | -135.65% | 101.75x | 1.00x | $-16.85K |
| 1999 | -20821.31% | -204.62% | 101.75x | 1.00x | $-25.41K |
| 2000 | 0.00% | -1012.24% | 1.10x | 0.00x | $-1.57 Million |
| 2001 | 0.00% | 0.00% | 0.00x | 0.00x | $-33.92K |
| 2002 | 0.00% | 0.00% | 0.00x | 0.00x | $1.37K |
| 2003 | 0.00% | -13.48% | 2.51x | 0.00x | $-56.51K |
| 2004 | -480.98% | -77.66% | 1.59x | 3.89x | $-996.17K |
| 2005 | 24.49% | 4.78% | 1.68x | 3.05x | $63.88K |
| 2006 | -24.88% | -12.53% | 0.92x | 2.15x | $-449.12K |
| 2007 | 58.92% | 26.48% | 1.12x | 1.98x | $1.77 Million |
| 2008 | 2.32% | 0.94% | 1.09x | 2.26x | $-366.46K |
| 2009 | 31.82% | 12.75% | 1.57x | 1.59x | $1.63 Million |
| 2010 | 4.28% | 1.45% | 1.53x | 1.92x | $-468.20K |
| 2011 | 15.42% | 4.58% | 1.57x | 2.15x | $550.00K |
| 2012 | 12.89% | 3.92% | 1.53x | 2.15x | $348.00K |
| 2013 | -149.55% | -33.67% | 1.26x | 3.53x | $-7.79 Million |
| 2014 | 0.00% | -55.76% | 1.56x | 0.00x | $-6.08 Million |
| 2015 | 0.00% | -25.01% | 3.15x | 0.00x | $-2.51 Million |
| 2016 | 0.00% | 0.52% | 3.25x | 0.00x | $440.30K |
| 2017 | 147.57% | 31.43% | 2.62x | 1.79x | $6.87 Million |
| 2018 | 101.76% | 29.93% | 1.97x | 1.72x | $8.61 Million |
| 2019 | 48.08% | 20.87% | 1.61x | 1.43x | $7.52 Million |
| 2020 | 15.96% | 11.33% | 1.08x | 1.31x | $3.39 Million |
| 2021 | 23.14% | 13.13% | 0.98x | 1.80x | $9.71 Million |
| 2022 | 25.69% | 10.78% | 1.31x | 1.81x | $10.41 Million |
| 2023 | 21.10% | 5.28% | 1.35x | 2.97x | $5.12 Million |
| 2024 | 8.38% | 1.56% | 1.58x | 3.42x | $-576.80K |
Industry Comparison
This section compares Zynex Inc's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,254,633,395
- Average return on equity (ROE) among peers: -3.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zynex Inc (ZYXI) | $-41.37 Million | -13803.28% | N/A | $1.36 Million |
| Accendra Health Inc (ACH) | $314.40 Million | 8.91% | 1.75x | $22.31K |
| Arjo AB (publ) (ARRJF) | $6.88 Billion | 10.78% | 1.12x | $491.29 Million |
| Cardinal Health Inc (CAH) | $255.60 Million | 13.15% | 1.57x | $49.75 Billion |
| Cencora Inc. (COR) | $4.01 Billion | 11.02% | 2.01x | $60.54 Billion |
| Cosmos Health Inc. (COSM) | $36.04 Million | -51.45% | 0.83x | $8.04 Million |
| EDAP TMS SA (EDAP) | $50.05 Million | 1.40% | 0.54x | $111.73 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $741.21K | -42.90% | 4.10x | $9.16 Million |
| Energy Management International Inc (ENMI) | $-362.21K | 0.00% | 0.00x | $383.13K |
| Exlites Holdings International Inc (EXHI) | $-84.27 | 0.00% | 0.00x | $574.58K |
| Galenica AG (GALNF) | $999.54 Million | 12.50% | 1.21x | $3.75 Billion |